Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
URMC drug extends effectiveness of HIV therapy

A drug developed at the University of Rochester Medical Center extends the effectiveness of multiple HIV therapies by unleashing a cell's own protective machinery on the virus. The finding, published today in the Journal of Clinical Investigation, is an important step towards the creation of long-acting HIV drugs that could be administered once or twice per year, in contrast to current HIV treatments that must be taken daily.

Published
31 January 2017
From
EurekAlert (press release)
Study shows how HIV breaches macrophage defenses, could be step towards cure

A team led by UCL researchers identified how HIV is able to infect macrophages, a type of white blood cell, despite the presence of a protective protein. They discovered a treatment to maintain macrophage defenses that could help lead to an HIV cure.

Published
26 January 2017
From
EurekAlert (press release)
Food is Medicine for HIV-Positive and Type 2 Diabetes Patients

HIV-positive people who received healthy food and snacks for six months were more likely to adhere to their medication regimens, were less depressed and less likely to make trade-offs between food and healthcare, according to a new study.

Published
26 January 2017
From
University of California San Francisco
Starting treatment quickly after diagnosis is not harmful for adolescents, Zimbabwe study finds

A lack of lengthy preparation before starting HIV treatment does not result in an increased risk of death or loss to follow-up in adolescents, a

Published
25 January 2017
By
Keith Alcorn
Federal program cuts disparities in HIV/AIDS care

In 2014, the safety-net program provided drugs, medical care and support services to more than 268,000 people in the U.S. living with human immunodeficiency virus (HIV) infections. Now a study shows that in 82 percent of them HIV is no longer detectable in their blood – a state known as “viral suppression.”

Published
24 January 2017
From
Reuters
Gene Therapy to Cure HIV: Where to from Here?

In a commentary published in AIDS Patient Care and STDs, amfAR Vice President and Director of Research Dr. Rowena Johnston discusses what needs to be done to overcome the barriers to gene therapy to cure HIV, including increasing the effectiveness of gene editing, targeting it to the right cells in the body, and optimizing the length of time it stays in the body to safely achieve its goal.

Published
24 January 2017
From
amfAR
High prevalence of low testosterone among younger and middle-aged ART-treated men in France

Around one in six young and middle-aged HIV-positive men doing well on antiretroviral therapy (ART) had low testosterone levels, French investigators report in the online edition of

Published
24 January 2017
By
Michael Carter
Regular small incentives can improve adherence to ART

The provision of regular low-value economic incentives can improve adherence to antiretroviral therapy (ART), according to research conducted in Uganda and published in the online

Published
23 January 2017
By
Michael Carter
Is the Hope for a Miracle Cure Just Magical Thinking?

I can’t stop myself from hoping that someday we will see a miracle cure and HIV will be history. I know this isn’t realistic. But whenever I see a mention of a miracle cure, I can’t stop myself from checking it out. Always disappointing. Should I give up hope?

Published
23 January 2017
From
HIV Plus
What are the key steps to effective delivery of PrEP care?

Providing pre-exposure prophylaxis (PrEP) to people who need it entails at least nine key steps, which can be conceived of as a PrEP continuum of care,

Published
20 January 2017
By
Roger Pebody

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.